Recall Z-1267-2024— ARROW INTERNATIONAL Inc.

Name: FDA recall Z-1267-2024
Creator: U.S. Food and Drug Administration
Published: 2024-02-12

Class I · Ongoing

Class I FDA medical device recall by ARROW INTERNATIONAL Inc., initiated 2024-02-12. It names one FDA 510(k) clearance: K160018. Product: ARROW QuickFlash Radial Artery Catherization (wire, guide, catheter), Part Numbers: a) REF AK-04220; b) REF ASK-04220-FMH1; c) REF ASK-04220-HHC; d) REF ASK-04220-KSP; e) REF ASK-04220-PSU; f) REF ASK-04220-UCL1; g) REF ASK-04500-AH; h) REF ASK-04500-HF-S; i) REF NA-04220-S1A; j) REF NA-04220-X1A; k) REF RA-04220; l) REF RA-04220-W. Reason: Teleflex is initiating this voluntary recall for the above-mentioned products due to reports received indicating a potentially defective component. The complaints received relate to resistance of the guidewire handle/chamber during use. The possible immediate health consequences of the component issue are arterial vasospasm and vessel injury arising from multiple arterial punctures with repeated attempts..

Recalling firm: ARROW INTERNATIONAL Inc.
Classification: Class I
Status: Ongoing
Initiated: 2024-02-12
Firm location: Morrisville, NC, United States

510(k) clearances named in this recall

1 on FDA's record

K160018 — Arrow Quickflash Arterial Catheterization DeviceArrow International, Inc. (Subsidiary of Teleflex, Inc.)·cleared 2016-06-13

K-numbers as listed on FDA's Recall Enterprise System record for this event (openFDA device/recall k_numbers). The recall may also cover devices cleared under other submissions not named here.

Product description

ARROW QuickFlash Radial Artery Catherization (wire, guide, catheter), Part Numbers: a) REF AK-04220; b) REF ASK-04220-FMH1; c) REF ASK-04220-HHC; d) REF ASK-04220-KSP; e) REF ASK-04220-PSU; f) REF ASK-04220-UCL1; g) REF ASK-04500-AH; h) REF ASK-04500-HF-S; i) REF NA-04220-S1A; j) REF NA-04220-X1A; k) REF RA-04220; l) REF RA-04220-W

Reason for recall

Teleflex is initiating this voluntary recall for the above-mentioned products due to reports received indicating a potentially defective component. The complaints received relate to resistance of the guidewire handle/chamber during use. The possible immediate health consequences of the component issue are arterial vasospasm and vessel injury arising from multiple arterial punctures with repeated attempts.

Data sourced from openFDA. This site is unofficial and independent of the FDA.